Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 1999, p. 422-426, Vol. 37, No. 2
Department of Microbiology, Prince of Wales
Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong
Kong, China
Received 29 June 1998/Returned for modification 12 August
1998/Accepted 31 October 1998
The appearance of colonies on the chromogenic medium CHROMagar
Candida combined with observation of morphology on corn meal-Tween 80 agar was used for the identification of 353 clinical yeast isolates.
The results were compared with those obtained with API yeast
identification kits. The accuracy of identification and the turnaround
time were equivalent for each method, and our cultural method was less expensive.
Identification to the species level
of yeasts isolated from clinical specimens is often problematic for
diagnostic laboratories, but it has become increasingly necessary.
Greater numbers of immunosuppressed patients, a widening range of
recognized pathogens, and the discovery of resistance to antifungal
drugs mean that the common practice of identification or exclusion of
Candida albicans alone is no longer adequate.
Reference procedures that use biochemical, morphological, and
temperature studies (4) are often not practicable for the clinical laboratory because they are labor-intensive and run over several weeks. Packaged kit systems are widely used, but they are
expensive and are limited by the sizes of their databases, while
automated systems have many of the same limitations.
With the favorable evaluation of CHROMagar Candida (CMA; CHROMagar
Company, Paris, France) (5, 10), we attempted to devise a
simple, rapid scheme for the routine identification of clinically important yeasts and also investigated whether it was possible to
extend the range of usefulness of the medium. We used colony appearance
on CMA in combination with morphology on corn meal-Tween 80 agar (CTA;
Oxoid, Basingstoke, United Kingdom) and compared our identifications
with the results obtained with the API 20C AUX or API 32C system.
A total of 352 yeast isolates and 1 isolate of the
achlorophyllous alga Prototheca wickerhamii, which has
yeast-like morphology on routine isolation media, were collected from
clinical specimens sent to our laboratory. Also included was an isolate
of the newly described yeast Candida dubliniensis, which we
had received as a specimen for identification in the Royal College of
Pathologists of Australasia's Quality Assurance Program.
Isolates were subcultured onto Sabouraud dextrose agar (Oxoid) and were
incubated at 30°C for 48 h. Single colonies were suspended in
sterile distilled water, and then the turbidity was adjusted to a
McFarland no. standard 2 with a spectrophotometer (Densimat; Biomerieux) for inoculation of API 20C AUX strips. These were incubated
at 30°C in air for 24 to 72 h. One loopful of the suspension was
streaked onto a 65-mm-diameter CMA plate to give isolated colonies. A
CTA plate was inoculated by the Dalmau method with yeasts from the same
colony from which the suspension had been prepared for examination of
morphology, including chlamydospore formation.
CMA plates were incubated at 37°C for 48 h in air, as
recommended by the manufacturer. CTA plates were incubated at 30°C in air for 48 h prior to examination. The diameters of yeasts which did not produce hyphae or pseudohyphae were measured with a calibrated microscope. Colony color on CMA plates and morphology on CTA plates were noted, and a preliminary identification was made by using these
features. The API strips were read, and the results were interpreted
with the corresponding identification software. The identities
determined by each method were compared. Isolates giving discordant
results were reexamined by the same protocol, except that the API 32C
system instead of the API 20C AUX system was used.
The results including the distinctive features on CMA and CTA
plates are summarized in Table 1. The
appearances on CMA plates and the microscopic morphologies on CTA
plates are given in Fig. 1. Of the 11 species,
none were incorrectly identified by the scheme with the CMA and CTA
plates, although when only a few isolates were available for study, a
confident identification could not be assumed. The API kits were not
able to identify two species, C. dubliniensis and P. wickerhamii, because these species were not included in the
database. The API kits incorrectly identified 1 of the 50 germ
tube-positive strains of C. albicans as Candida parapsilosis and identified all strains of Candida
krusei and Candida guilliermondii with only a low level
of confidence.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Simple, Reliable, and Cost-Effective Yeast
Identification Scheme for the Clinical Laboratory
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
RESULTS
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
TABLE 1.
Identification of clinical yeast isolates by API kits or
the combination of CMA plus CTA, including growth characteristics on
these media

View larger version (125K):
[in a new window]

View larger version (79K):
[in a new window]
FIG. 1.
Appearances of colonies on CMA (left; magnification,
×1) and microscopic appearance on CTA (right; magnification, ×400)
after 48 h of incubation. (A) C. albicans. (B) C. dubliniensis. (C) C. tropicalis. (D) T. beigelii. (E) C. krusei. (F) C. glabrata.
(G) C. parapsilosis. (H) C. neoformans. (I)
C. guilliermondii. (J) S. cerevisiae. (K)
P. wickerhamii.
| |
DISCUSSION |
|---|
|
|
|---|
A number of researchers have found CMA to be effective for the presumptive identification of C. albicans, Candida tropicalis, and Trichosporon (5, 10). Pfaller et al. (7) also found it to be reliable for the presumptive identification of Candida glabrata, although others (5, 10) did not concur with this. We found that C. glabrata could not be distinguished by its appearance on CMA plates alone, having an appearance similar to those of C. parapsilosis, Saccharomyces cerevisiae, P. wickerhamii, Cryptococcus neoformans, and C. guilliermondii. However, the addition of information from CTA plates does allow identification, so that except for rare isolates of Candida famata, clinical yeasts that form pink glossy colonies on CMA but that have small yeast cells and no pseudomycelium on CTA can presumptively be identified as C. glabrata.
C. krusei can reliably be identified with the combination of CMA and CTA, having a distinctive morphology on both media, whereas kit systems do not cope well with this species. Pigment production by C. tropicalis on CMA allows discrimination of this species with >99% confidence (5). Trichosporon beigelii has a variable but distinctive appearance on CMA, with small dry-looking colonies, and the formation of arthroconidia on CTA gives a reliable confirmation of its identity. Other arthroconidium-forming species such as Coccidioides immitis, which takes much longer than 2 days to form arthroconidia, and Geotrichum candidum, which is a mold, will not be confused with Trichosporon on this medium.
C. neoformans colonies on CMA are a nondistinctive pink and may be mucoid. Dalmau plate morphology reveals large round yeast cells, often with the presence of capsules, suggesting the identity of C. neoformans. The clinical importance of C. neoformans requires confirmation of its identity by serological or biochemical methods.
The achlorophyllous alga P. wickerhamii, which may cause wound infections and meningitis (2, 13), has a yeast-like colony morphology on Sabouraud and blood agars and can easily be mistaken for a yeast. The API 20C AUX and API 32C systems identify it as C. glabrata because both species assimilate only glucose and trehalose among the sugars in the panel and P. wickerhamii is not included in the databases. Without observation of morphology, it might be reported as C. glabrata, but on CMA distinctive sporangia varying in size from 5 to 25 µm are readily observed.
Definitive identification of the newly described
chlamydospore-positive, germ tube-positive species C. dubliniensis requires testing for
-glucosidase activity, an
expensive and not widely available test (8), or DNA
fingerprinting, which demonstrates the nonreactivity of its DNA with a
C. albicans-specific oligonucleotide probe, Ca3 or 27A
(6, 11, 12). Phenotypic tests would be more practical for
clinical laboratory screening for this species. C. dubliniensis has much darker green colonies than C. albicans on CMA, and it usually produces abundant chlamydospores
(1, 3, 11, 12). Chlamydospore formation in C. dubliniensis is radically different from that in C. albicans, with chlamydoconidia often attached in pairs, triplets,
or larger clusters to the same suspensor cell rather than singly at the
ends of hyphae or pseudohyphae as in C. albicans
(1), although this characteristic may not be present in all
strains (11). The formation of dark green colonies on CMA
may be lost on repeated subculture or storage at
70°C
(11). It does not fluoresce under Woods lamp illumination on
methyl blue-Sabouraud agar, unlike C. albicans, although
this property may also be lost on subculture (3, 11). Only
one isolate of C. dubliniensis was available to the
researchers, and this strain had been subcultured a number of times,
yet it retained the ability to form dark green colonies on CMA. The
growth of C. dubliniensis at 42°C is poor relative to that
of C. albicans, and C. dubliniensis not grow at
all at 45°C, although some strains of C. albicans also
fail to grow at this temperature (8). Differential growth at
one of these temperatures has been suggested as a useful method for
differentiation between the two species (1, 3, 8, 9, 11,
12). Carbohydrate assimilation patterns have been reported to be
unstable (1, 11), although the failure of C. dubliniensis to assimilate both xylose and
-methyl-D-glucoside compared with the utilization of one
or both of these by C. albicans has been suggested as a
useful test (9). It is important to differentiate between
these species, because significant resistance to azoles has been
reported in C. dubliniensis (12). We suggest initial screening with CMA and CTA and then confirmation with examination for growth at 42 or 45°C as a useful method for the presumptive identification of C. dubliniensis.
The turnaround time of 48 h for the CMA and CTA scheme is similar to that for commercial kit systems, which require 24 to 72 h. The average time taken by experienced technicians to set up and read CMA and CTA plates is 3 min per isolate, while the average time taken to set up and read an API strip is 10 to 15 min. The estimated cost of materials per isolate for the CMA and CTA plates is US$1 when 65-mm petri dishes are used for CMA and when four strains are tested on a 90-mm plate for CTA. We pay US$5.20 for each API strip.
It is important that isolated colonies be observed on CMA because the identifying descriptions are based on the form, color, and pigment production of single colonies. Recognition of yeast morphologies on Dalmau plates requires some experience, but once this is mastered, it has been our experience that laboratory staff find the scheme simple and reliable. We were able to use this scheme to identify more than 95% of yeast isolates in our laboratory.
Advances in medical technology have not fostered the development of traditional mycology skills among medical laboratory personnel, yet these skills are increasingly needed. Careful observation of yeast morphology can add confidence to the identification of the commonly encountered species and, more importantly, will alert the microbiologist to the presence of unusual isolates whose misidentification may have serious clinical implications.
| |
FOOTNOTES |
|---|
* Corresponding author. Present address: Infectious Diseases Laboratories, Institute of Medical and Veterinary Science, P.O. Box 14, Rundle Mall, Adelaide, SA 5000, Australia. Phone: 61-8-8222 3144. Fax: 61-8-8222 3543. E-mail: ann.koehler{at}imvs.sa.gov.au.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Coleman, D. C., D. J. Sullivan, D. E. Bennett, G. P. Moran, H. J. Barry, and D. B. Shanley. 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11:557-567[Medline]. |
| 2. | Kaminski, Z. C., R. Kapila, L. R. Sharer, P. Kloser, and L. Kaufman. 1992. Meningitis due to Prototheca wickerhamii in a patient with AIDS. Clin. Infect. Dis. 15:704-706[Medline]. |
| 3. |
Kirkpatrick, W. R.,
S. G. Revankar,
R. K. McAtee,
J. L. Lopez-Ribot,
A. W. Fothergill,
D. I. McCarthy,
S. E. Sanche,
R. A. Cantu,
M. G. Rinaldi, and T. F. Patterson.
1998.
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates.
J. Clin. Microbiol.
36:3007-3012 |
| 4. | Kreger-van Rij, N. J. W. (ed.). 1984. The yeasts: a taxonomic study, 3rd ed. Elsevier Science Publishers, Amsterdam, The Netherlands. |
| 5. |
Odds, F. C., and R. Bernaerts.
1994.
CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.
J. Clin. Microbiol.
32:1923-1929 |
| 6. |
Odds, F. C.,
L. Van Nuffel, and G. Dams.
1998.
Prevalence of Candida dubliniensis isolates in a yeast stock collection.
J. Clin. Microbiol.
36:2869-2873 |
| 7. | Pfaller, M. A., A. Houston, and S. Coffmann. 1996. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J. Clin. Microbiol. 34:58-61[Abstract]. |
| 8. |
Pinjon, E.,
D. Sullivan,
I. Salkin,
D. Shanley, and D. Coleman.
1998.
Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans.
J. Clin. Microbiol.
36:2093-2095 |
| 9. |
Salkin, I. F.,
W. R. Pruitt,
A. A. Padhye,
D. Sullivan,
D. Coleman, and D. H. Pincus.
1998.
Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States.
J. Clin. Microbiol.
36:1467 |
| 10. | San-Millan, R., L. Ribacoba, J. Ponton, and G. Quindos. 1996. Evaluation of a commercial medium for identification of Candida species. Eur. J. Clin. Microbiol. Infect. Dis. 15:153-158[Medline]. |
| 11. | Schoofs, A., F. C. Odds, R. Colebunders, M. Ieven, and H. Goossens. 1998. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 16:296-300. |
| 12. |
Sullivan, D., and D. Coleman.
1998.
Candida dubliniensis: characteristics and identification.
J. Clin. Microbiol.
36:329-334 |
| 13. | Tang, W. Y. M., K. K. Lo, W. Y. Lam, K. S. C. Fung, A. Koehler, and A. F. B. Cheng. 1995. Cutaneous protothecosis: report of a case in Hong Kong. Br. J. Dermatol. 133:479-482[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»